News

Call for Applications: MIT-GSK Gertrude B. Elion Research Fellowship Program for Drug Discovery and Disease

Introduction Massachusetts Institute of Technology and GlaxoSmithKline are pleased to announce a new initiative to support research at MIT. The MIT-GSK Gertrude B. Elion Research Fellowship Program for Drug Discovery and Disease will fund up to three selected Fellows to conduct post-doctoral research at MIT, with a goal of promoting…

Read More

Using machine learning to improve patient care

New CSAIL research employs many types of medical data, including electronic health records, to predict outcomes in hospitals. Doctors are often deluged by signals from charts, test results, and other metrics to keep track of. It can be difficult to integrate and monitor all of these data for multiple patients…

Read More

HST student Shriya Srinivasan improves amputation process

MEMP student Shriya Srinivasan, studying in the Harvard-MIT Health Sciences and Technology program (HST), the degree-granting educational arm of IMES, is featured in the September-October 2017 issue of Harvard Magazine for her work to improve the process for performing amputations. “Today’s state-of-the-art prosthetic limbs are scientific marvels, designed with robotics and sensors that…

Read More

Charles River World Congress on Animal Models in Drug Discovery & Development

Charles River has proudly partnered with the EBD Group to provide the scientific program for this year’s BioPharm America™ Conference. This exciting two-day program aims to bridge the gap between drug discovery and clinical application. Driven by the bedside-to-bench experience, industry leaders will come together to discuss innovations and breakthroughs…

Read More